/Investor DB

NCL Technology Ventures Ltd. — 2019 Investments

1 investments dated 2019 · listed companies and verified rows first · show all

Azadyneazadyne.cominMar 2019

Azadyne is a UK biotech company and spin-out from Trinity College Dublin developing therapeutics based on tRNA modification and epigenetic regulation of cellular protein synthesis.

BiotechDeep Tech

Vincent KellyStephen Connonin

BoardJason Rutt

Co-investors24 Haymarket

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.